Cantor Bioconnect Inc.

UEI
NRDSNN258AJ9
CAGE
8YPN9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $33,065

Contract awards

Award Agency Obligated Awarded
Lesion swabs 75D30123P16653 CDC Pittsburgh $33,065

Contract subawards

Prime contractor Prime award Amount Awarded
Battelle Memorial Institute ADVANCED THREATS RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE… FA807522F0014 $115,200
Battelle Memorial Institute ADVANCED THREATS RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE… FA807522F0014 $46,200
Battelle Memorial Institute ADVANCED THREATS RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE Swabs… FA807522F0014 $42,000

Similar vendors

About the company

Cantor Bioconnect Inc., registered in SAM.gov since February 2021 and located in Santee, California, is a for-profit Subchapter S Corporation specializing in medical and scientific supplies. The company appears to focus on providing specialized medical collection and sampling equipment, with a particular emphasis on specimen collection tools. As a corporate entity, Cantor Bioconnect operates with a current SAM.gov registration valid through January 2026, indicating its ongoing commitment to federal government contracting opportunities.

The company has demonstrated federal contracting capabilities through specific awards involving medical specimen collection equipment, particularly lesion and human specimen swabs. Its federal contract history includes a prime award from the CDC Pittsburgh for lesion swabs, valued at $33,065, completed in June 2023. Additionally, Cantor Bioconnect has secured two significant sub-contract awards with Battelle Memorial Institute, dated March 2025 and June 2024, specifically for purchasing lesion swabs and swabs designed to collect human specimens. These contracts suggest the company provides critical medical sampling equipment to federal research and public health institutions. The contracts were not set-aside and were executed through standard purchase order mechanisms, reflecting the company's ability to compete in open federal procurement processes.

Quick answers

Is Cantor Bioconnect Inc. registered in SAM.gov?

Cantor Bioconnect Inc.'s SAM.gov registration expired on January 28, 2026.

How much has Cantor Bioconnect Inc. received in federal contracts?

Federal contracts obligated $33,065 to Cantor Bioconnect Inc. in fiscal years 2023 through 2027.

What is Cantor Bioconnect Inc.'s most recent federal award?

Cantor Bioconnect Inc.'s most recent federal contract award is Lesion swabs (75D30123P16653), from CDC Pittsburgh, on June 1, 2023.

On GovTribe

See Cantor Bioconnect Inc.'s full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors